2656 — 160 Health International Income Statement
0.000.00%
Last trade - 00:00- HK$7.79bn
- HK$7.61bn
- CNY651.87m
Annual income statement for 160 Health International, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 526 | 629 | 621 | 652 |
| Cost of Revenue | ||||
| Gross Profit | 118 | 137 | 160 | 170 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 605 | 728 | 725 | 726 |
| Operating Profit | -79.2 | -99.5 | -105 | -74.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -119 | -111 | -107 | -77.3 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -119 | -111 | -108 | -74.5 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -111 | -109 | -108 | -73 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -111 | -109 | -108 | -73 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.329 | -0.3 | -0.288 | -0.177 |